HuCAL

Type: Product
Name: HuCAL
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

Celibate sisters: looking to your sorority for support

T his is a love letter to Greek letters, but it will not mention bid-day, parties, philanthropy or awards. It is not going to tell you to go through recruitment or which fraternities have the hottest men or which stereotypes are true. This is a story ... [Published Nevada Sagebrush - Sep 16 2014]
Entities: Recruitment, Sex, HuCAL
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

MorphoSys Receives Research Grant to Develop Novel Therapeutic Antibodies Targeting GPCRs

World News: 06:31 GMT Monday 15th September 2014 . [ MorphoSys AG via Thomson Reuters ONE via SPi World News ]This storyMorphoSys AG /MorphoSys Receives Research Grant to Develop Novel Therapeutic AntibodiesTargeting GPCRs. Processed and transmitted by ... [Published SPi World News - Sep 15 2014]
First reported Sep 12 2014 - Updated Sep 12 2014 - 1 reports

Hogan Lovells advises MorphoSys on cooperation with Emergent BioSolutions

MorphoSys, a TecDax listed company, has announced a licensing agreement with Emergent BioSolutions for the joint development and commercialization of the drug candidate ES414 targeting prostate cancer. The compound ES414, to be renamed MOR209/ES414, was ... [Published Hogan Lovells - Sep 12 2014]
First reported Sep 09 2014 - Updated Sep 09 2014 - 1 reports

The Bunny Ranch : The respectable life of working women

By Anneliese HucalThe first time I stepped foot into the Moonlite Bunny Ranch Brothel I was awestruck by the glitter, silicone and long hair extensions of the squadron of sexy women working there. I remember staring at a particularly normal-looking girl ... [Published Nevada Sagebrush - Sep 09 2014]
First reported Aug 28 2014 - Updated Aug 28 2014 - 1 reports

WAG Honours Collectors with Bringing Shadow to Light Exhibition

: Throughout its more than one-hundred year history, the Winnipeg Art Gallery has benefited enormously from countless generous and discriminating individuals, families, and foundations who have donated their prized objects and contributed to the Gallery's ... [Published Noodls - Aug 28 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

Sex talk without all the shame

by Anneliese HucalFor those of you that don't know me, my name is Anneliese and I am a storyteller. I specifically like to tell stories about sexual- ity, which is both the lifeblood and the bane of my existence.People are rather funny about sex. While ... [Published Individual.com - Aug 26 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

DENTAC welcomes new commander

Col. David Kryszak relinquished command of the Fort Leonard Wood Dental Activity to Col. Alex Eke during a ceremony Friday in the John B. Mahaffey Museum Complex.Col. George Hucal, Western Regional Dental Command commander, officiated the event.“I am ... [Published Guidon - Aug 21 2014]
First reported Aug 20 2014 - Updated Aug 20 2014 - 2 reports

MorphoSys to Host Conference Call on License Agreement with Emergent to Co-Develop and Commercialize Prostate Cancer Drug Candidate MOR209/ES414

World News: 06:34 GMT Wednesday 20th August 2014 . [ MorphoSys AG via Globe Newswire via SPi World News ]This storyMARTINSRIED / MUNICH, Germany, Aug. 20, 2014 (GLOBE NEWSWIRE)On 19 August 2014, MorphoSys and Emergent BioSolutions Inc. announced an agreement ... [Published SPi World News - Aug 20 2014]
First reported Jun 17 2014 - Updated Jun 17 2014 - 1 reports

Monoclonal antibodies against ANGPTL3

Monoclonal antibodies that specifically bind to ANGPTL3 are provided. Monoclonal antibodies that neutralize at least one activity of ANGPTL3 are provided. Methods of treating a disorder of lipid metabolism using neutralizing monoclonal antibodies are ... [Published PharmCast - Jun 17 2014]

Quotes

"We are delighted to receive this valuable support from the German government. Our Ylanthia platform is the perfect fit for therapeutic antibody discovery, especially against technically challenging targets. By applying our antibody capabilities to the discovery of novel therapeutics against GPCRs, we are opening up a whole range of new product opportunities" commented Dr. Marlies Sproll, Chief Scientific Officer of MorphoSys AG
"Small and quickly executed preparatory sketches and studies-objects that play an indelible role in an artist`s creative process-earn equal attention to finished canvases, final proofs, and end products, for example, raising the WAG's capacity to facilitate important primary re" states Kear...
be, "How much control of the world around me do I need to have in order to be comfortable?"
...and biotech companies that we expect to see during the course of the year," commented Dr Marlies Sproll, chief scientific officer of MorphoSys AG. "In total, our collaboration with Novartis has resulted in eight clinical antibodies to date, three currently being in phase I development, four in phase II and one in a pivotal trial."

More Content

All (13) | News (12) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
Celibate sisters: looking to your sorority for ... [Published Nevada Sagebrush - Sep 16 2014]
MorphoSys Receives Research Grant to Develop No... [Published SPi World News - Sep 15 2014]
Hogan Lovells advises MorphoSys on cooperation ... [Published Hogan Lovells - Sep 12 2014]
The Bunny Ranch : The respectable life of worki... [Published Nevada Sagebrush - Sep 09 2014]
WAG Honours Collectors with Bringing Shadow to ... [Published Noodls - Aug 28 2014]
Sex talk without all the shame [Published Individual.com - Aug 26 2014]
DENTAC welcomes new commander [Published Guidon - Aug 21 2014]
MorphoSys to Host Conference Call on License Ag... [Published SPi World News - Aug 20 2014]
MorphoSys to Host Conference Call on License Ag... [Published BusinessWeek - Aug 20 2014]
REG-Ad hoc: MorphoSys and Emergent BioSolutions... [Published Reuters - Aug 19 2014]
MorphoSys AG Reports Results for the First Six ... [Published GlobeNewswire: Advertising News - Jul 28 2014]
Monoclonal antibodies against ANGPTL3 [Published PharmCast - Jun 17 2014]
MorphoSys gets clinical milestone from Novartis... [Published PharmaBiz - Feb 18 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Press Releases

sort by: Date | Relevance
MorphoSys AG Reports Results for the First Six ... [Published GlobeNewswire: Advertising News - Jul 28 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.